HEADLINE STOCKS-U.S. stocks on the move on June 4

(Updates to afternoon trade, adds Signet, Fifth Third, Novavax, Travelers, Anadys, Saks, Wet Seal, Abercrombie, Ross Stores, TJX and Buckle)

HEADLINE STOCKS-U.S. stocks on the move on June 4

(Updates to after the open, adds Johnson & Johnson, Target, Gap, American Eagle, Aeropostale, Hartford, Wind River/Intel)

HEADLINE STOCKS-U.S. stocks to watch on June 4

NEW YORK, June 4 (Reuters) - Some U.S. stocks to watch on June 4:

UPDATE 1-Adolor to cut 28 pct jobs, sees charge in Q2

* Expects to end FY09 with $85 mln in cash, investments

US RESEARCH SUMMARY-Non-S&P 500 March 20 2048 GMT

 Following is a summary of research actions on non-S&P 500 companies reported

	

UPDATE 1-Adolor to stop development of bowel dysfunction drug

Dec 18 (Reuters) - Biopharmaceutical company Adolor Corp said it will stop developing its experimental treatment for chronic bowel dysfunction in patients on opioid therapy to conserve cash.

FACTBOX-US regulators missing drug review deadlines

Oct 17 (Reuters) - Some U.S. deadlines for reviewing new drugs have come and gone without a decision from the Food and Drug Administration. [ID:nN02287148]

UPDATE 1-RESEARCH ALERT-Brean Murray upgrades Adolor to buy

Sept 8 (Reuters) - Brean Murray Carret & Co upgraded Adolor Corp to "buy" from "hold," based on an optimistic view on the company's bowel drug, Entereg.

US RESEARCH SUMMARY-Non-S&P 500 Sept 3 1530 GMT

Following is a summary of research actions on non-S&P 500 and Canadian companies reported by Reuters on Wednesday. Stock entries are in alphabetical order. For a summary of research on S&P 500 companies, double click on [RCH/US] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Adolor Piper Jaffray Cuts to neutral from buy,